Zhao C, Xu R, Yan W, Jiang B, Feng S, Wang X
Animals (Basel). 2024; 14(21).
PMID: 39518840
PMC: 11545013.
DOI: 10.3390/ani14213118.
Yang J, Ren Z, Wang F, Zheng J, Zhuang Z, Zeng Y
Am J Cancer Res. 2024; 14(5):2408-2423.
PMID: 38859859
PMC: 11162669.
DOI: 10.62347/FLIM3367.
Issa H, Loubaki L, Al Amri A, Zibara K, Almutairi M, Rouabhia M
Sci Rep. 2024; 14(1):10958.
PMID: 38740853
PMC: 11091204.
DOI: 10.1038/s41598-024-60754-8.
Dzhemileva L, Tuktarova R, Dzhemilev U, Dyakonov V
Cancers (Basel). 2023; 15(3).
PMID: 36765714
PMC: 9913425.
DOI: 10.3390/cancers15030756.
Smith M, Forbes Satter L, Vargas-Hernandez A
Front Immunol. 2023; 13:1025373.
PMID: 36755813
PMC: 9899847.
DOI: 10.3389/fimmu.2022.1025373.
Growth hormone and gastrointestinal malignancy: An intriguing link.
Palui R, Sridharan K, Kamalanathan S, Sahoo J, Naik D
World J Gastrointest Pathophysiol. 2023; 14(1):1-11.
PMID: 36743656
PMC: 9896462.
DOI: 10.4291/wjgp.v14.i1.1.
In-depth analysis of the expression and functions of signal transducers and activators of transcription in human ovarian cancer.
Gong X, Liu X
Front Oncol. 2022; 12:1054647.
PMID: 36524006
PMC: 9745122.
DOI: 10.3389/fonc.2022.1054647.
Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor.
Abu El-Makarem M, Kamel M, Mohamed A, Ali H, Mohamed M, Mohamed A
PLoS One. 2022; 17(11):e0277266.
PMID: 36374927
PMC: 9662744.
DOI: 10.1371/journal.pone.0277266.
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer.
Yang Y, Luo D, Shao Y, Shan Z, Liu Q, Weng J
Cancer Commun (Lond). 2022; 43(1):100-122.
PMID: 36328987
PMC: 9859733.
DOI: 10.1002/cac2.12380.
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers.
Ni Y, Low J, Silke J, OReilly L
Front Immunol. 2022; 13:835997.
PMID: 35844493
PMC: 9277720.
DOI: 10.3389/fimmu.2022.835997.
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Li Z, Chen C, Chen L, Hu D, Yang X, Zhuo W
Front Oncol. 2021; 11:697950.
PMID: 34336684
PMC: 8320598.
DOI: 10.3389/fonc.2021.697950.
Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia.
Wang Z, Mi T, Bradley H, Metts J, Sabnis H, Zhu W
Antioxidants (Basel). 2021; 10(6).
PMID: 34203664
PMC: 8232307.
DOI: 10.3390/antiox10060956.
Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2.
Zhang X, Wu L, Kong X, Zheng B, Zhang Z, He Z
World J Clin Cases. 2021; 9(7):1513-1523.
PMID: 33728295
PMC: 7942047.
DOI: 10.12998/wjcc.v9.i7.1513.
A centric view of JAK/STAT5 in intestinal homeostasis, infection, and inflammation.
Surbek M, Tse W, Moriggl R, Han X
Cytokine. 2021; 139:155392.
PMID: 33482575
PMC: 8276772.
DOI: 10.1016/j.cyto.2020.155392.
Targeting BRD9 for Cancer Treatment: A New Strategy.
Zhu X, Liao Y, Tang L
Onco Targets Ther. 2020; 13:13191-13200.
PMID: 33380808
PMC: 7769155.
DOI: 10.2147/OTT.S286867.
ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.
Kim G, Lee C, Verma R, Rudra D, Kim T, Kang K
Front Oncol. 2020; 10:642.
PMID: 32477936
PMC: 7239993.
DOI: 10.3389/fonc.2020.00642.
Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer.
Gasparyan M, Lo M, Jiang H, Lin C, Sun D
J Biol Chem. 2020; 295(34):12188-12202.
PMID: 32467227
PMC: 7443492.
DOI: 10.1074/jbc.RA119.010710.
Unphosphorylated STAT3 in heterochromatin formation and tumor suppression in lung cancer.
Dutta P, Zhang L, Zhang H, Peng Q, Montgrain P, Wang Y
BMC Cancer. 2020; 20(1):145.
PMID: 32087696
PMC: 7036253.
DOI: 10.1186/s12885-020-6649-2.
Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells.
Akiyama H, Umezawa Y, Watanabe D, Okada K, Ishida S, Nogami A
Cancers (Basel). 2020; 12(2).
PMID: 32050632
PMC: 7072561.
DOI: 10.3390/cancers12020406.
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.
Brachet-Botineau M, Polomski M, Neubauer H, Juen L, Hedou D, Viaud-Massuard M
Cancers (Basel). 2020; 12(1).
PMID: 31963765
PMC: 7016966.
DOI: 10.3390/cancers12010240.